Physician profile
Mitchell J Thompson
NPI 1568996692
$3,738.07
in general payments reported to CMS, 2019-2025
15 companies · $51.68 in 2025
The $51.68 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $288 · 2021: $1,592 · 2022: $788 · 2023: $390 · 2024: $137 · 2025: $51.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossio INC | $1,000.00 | 2021 | |
| Stryker Corporation | $658.52 | 2021-2023 | Easyfuse, Ortholoc 3di |
| Integra Lifesciences Corporation | $395.43 | 2019-2020 | |
| Paragon 28, INC. | $293.31 | 2019-2022 | |
| Medline Industries LP | $202.35 | 2021-2025 | |
| Medical Device Business Services, INC. | $201.08 | 2019 | |
| In2bones USA, LLC | $188.80 | 2021 | |
| Anika Therapeutics, INC. | $155.69 | 2022 | |
| Djo, LLC | $144.45 | 2021 | |
| True North Surgical INC | $139.54 | 2023 | |
| Linvatec Corporation | $121.79 | 2024 | Colink Mfx, Biobrace 23mm |
| Trimed, INC. | $114.82 | 2022 | |
| Great Lakes Orthopedics | $89.37 | 2020 | |
| Acera Surgical, INC. | $17.45 | 2025 | Restrata Wound Matrix |
| Kerecis Limited | $15.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.